Efficacy of Topical Cyclosporin for Ocular Rosacea

Completed · Phase 4

Conditions studied: Rosacea

In brief

The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea

Key facts

Study ID

NCT00348335

Run by

Ophthalmic Consultants of Long Island

People needed

35

Starts

2006-06-01

Expected to finish

2007-09-01

Last updated by the study team

2011-07-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patient at least 18 years old, but younger than 65
• Diagnosis of acne rosacea
• Active ocular rosacea based on lid findings of meibomian gland dysfunction with lid telangiectasia and hyperemia of at least 2+
• Schirmers test of greater than 5mm in at least 1 eye
• If patient currently using lid hygiene must maintain regimen during study
• Stop oral antibiotics at least 4 weeks prior

You may not qualify if…

• Use of topical cyclosporin within last 90 days
• Visual acuity of 20/100 or better in both eyes
• Pregnant or lactating females
• Active ocular infection
• Scarring of central cornea
• Eyelid defects,abnormal lid positioning or lagophthalmos
• Flax seed or Fish oil supplements within last 30 days

Where it is running

• 2500 Rte 347 Bldg 24 — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.